Literature DB >> 30788760

Nuclear cardio-oncology: From its foundation to its future.

Milan G Kahanda1, Christopher A Hanson1, Brandy Patterson1, Jamieson M Bourque2,3.   

Abstract

Cardio-oncology is a growing field focused on the prevention and treatment of cardiovascular disease in oncologic patients. While a major focus of chemotherapy-related cardiac dysfunction has been on left ventricular ejection fraction, oncologic treatment can lead to cardiovascular pathology in a variety of ways. The use of multimodality imaging is essential to the care of these patients, with nuclear cardiology playing an important role. We will review nuclear cardiology's history, its current role, and its promising future in cardio-oncology and the management of these patients.

Entities:  

Keywords:  Cardiomyopathy; Diagnostic and prognostic application; Metabolic; Molecular imaging agents; Multimodality

Year:  2019        PMID: 30788760     DOI: 10.1007/s12350-019-01655-6

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  44 in total

Review 1.  Cardiovascular Toxic Effects of Targeted Cancer Therapies.

Authors:  Javid J Moslehi
Journal:  N Engl J Med       Date:  2016-10-13       Impact factor: 91.245

2.  A clinicopathologic analysis of adriamycin cardiotoxicity.

Authors:  E A Lefrak; J Pitha; S Rosenheim; J A Gottlieb
Journal:  Cancer       Date:  1973-08       Impact factor: 6.860

Review 3.  Cardio-Oncology: An Update on Cardiotoxicity of Cancer-Related Treatment.

Authors:  Carrie G Lenneman; Douglas B Sawyer
Journal:  Circ Res       Date:  2016-03-18       Impact factor: 17.367

4.  Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis.

Authors:  Javid J Moslehi; Joe-Elie Salem; Jeffrey A Sosman; Bénédicte Lebrun-Vignes; Douglas B Johnson
Journal:  Lancet       Date:  2018-03-10       Impact factor: 79.321

Review 5.  Anthracycline-induced cardiotoxicity.

Authors:  K Shan; A M Lincoff; J B Young
Journal:  Ann Intern Med       Date:  1996-07-01       Impact factor: 25.391

6.  Cancer statistics, 2016.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2016-01-07       Impact factor: 508.702

7.  Anthracycline-induced cardiotoxicity: a review of pathophysiology, diagnosis, and treatment.

Authors:  Shashi Raj; Vivian I Franco; Steven E Lipshultz
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-06

8.  Adriamycin cardiomyopathy--risk factors.

Authors:  R A Minow; R S Benjamin; E T Lee; J A Gottlieb
Journal:  Cancer       Date:  1977-04       Impact factor: 6.860

Review 9.  Management of chemotherapy induced cardiomyopathy.

Authors:  Abdulfattah Saidi; Rami Alharethi
Journal:  Curr Cardiol Rev       Date:  2011-11

Review 10.  Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention.

Authors:  Adriana Albini; Giuseppina Pennesi; Francesco Donatelli; Rosaria Cammarota; Silvio De Flora; Douglas M Noonan
Journal:  J Natl Cancer Inst       Date:  2009-12-10       Impact factor: 13.506

View more
  3 in total

1.  Low-dose gated bloodpool SPECT: Is it time to make the shift?

Authors:  Laetitia Imbert; Pierre-Yves Marie
Journal:  J Nucl Cardiol       Date:  2019-08-29       Impact factor: 5.952

2.  Chemotherapy-induced Cardiac18F-FDG Uptake in Patients with Lymphoma: An Early Metabolic Index of Cardiotoxicity?

Authors:  Mayara L C Dourado; Luca T Dompieri; Glauber M Leitão; Felipe A Mourato; Renata G G Santos; Paulo J Almeida Filho; Brivaldo Markman Filho; Marcelo D T Melo; Simone C S Brandão
Journal:  Arq Bras Cardiol       Date:  2022-05-02       Impact factor: 2.667

Review 3.  Emerging Challenges of Radiation-Associated Cardiovascular Dysfunction (RACVD) in Modern Radiation Oncology: Clinical Practice, Bench Investigation, and Multidisciplinary Care.

Authors:  Moon-Sing Lee; Dai-Wei Liu; Shih-Kai Hung; Chih-Chia Yu; Chen-Lin Chi; Wen-Yen Chiou; Liang-Cheng Chen; Ru-Inn Lin; Li-Wen Huang; Chia-Hui Chew; Feng-Chun Hsu; Michael W Y Chan; Hon-Yi Lin
Journal:  Front Cardiovasc Med       Date:  2020-02-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.